BCL2 and autism: Upregulated expression of the mitochondrial aspartate/glutamate carrier (SLC25A12) [18,19], and evidence of hypoxia, as measured by a reduction in the anti-apoptotic protein Bcl-2 and an increase in the pro-apoptotic protein p53 [20,21], has also been reported in autism brain.